Clinical Trial Update: Abciximab in Wake-up Stroke [Phase 3]

View source ↗

Summary

Phase 3 trial of abciximab for wake-up stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Abciximab (abciximab)

Snippet

Sponsor: University of Zurich | Conditions: Stroke | Phase 3 | Status: TERMINATED